HighPoint Blog

The increase in tendering as well as the entry of multiple biosimilars is disrupting the healthcare market in Europe, with plenty of new players and procedures. This blog looks at how the perspective of game theory could support understanding of these market dynamics.

Read More

Recent Posts

Tag